Results 181 to 190 of about 3,156,256 (308)

Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati, Sami I. Nassar, Shaun A. Nguyen, Patricia L. Gerend, Michael C. Schubert, Michael T. Teixido, Frederick A. Godley, Joel A. Goebel, Cynthia A. Ryan, Habib G. Rizk, Amir Kheradmand   +10 more
wiley   +1 more source

Positive symptoms and their associations with life and trauma events among young adults in a first-episode psychosis clinic: qualitative analysis. [PDF]

BJPsych Open
Ternamian AA, Marchal M, Haesebaert J, Haesebaert F.   +3 more
europepmc   +1 more source

Positive Symptoms in Antipsychotic-naïve Schizophrenia are Associated with Increased Body Mass Index after Treatment. [PDF]

Clin Psychopharmacol Neurosci, 2021
Lin SH, Tseng HH, Tsai HC, Chi MH, Lee IH, Chen PS, Chen KC, Yang YK.   +7 more
europepmc   +1 more source

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I. Bohnen, Roger L. Albin   +6 more
wiley   +1 more source

Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder. [PDF]

Schizophr Res
Corbera S, Wexler BE, Bell MD, Pittman B, Pelphrey K, Pearlson G, Assaf M.   +6 more
europepmc   +1 more source

Reduced TMS-evoked fast oscillations in the motor cortex predict the severity of positive symptoms in first-episode psychosis. [PDF]

Prog Neuropsychopharmacol Biol Psychiatry, 2021
Donati FL, Kaskie R, Reis CC, D'Agostino A, Casali AG, Ferrarelli F.   +5 more
europepmc   +1 more source

The effect of geranium tea on menopausal symptoms [PDF]

Background: The increase in life expectancy in women, the presence of complications and hardships associated with menopause, and the side effects of hormonal treatment have led to endeavors for improving the quality of life in women during the menopause ...
شهباززادگان, سمیرا
core  

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen, Ceren Tozlu, Tina Roostaei, Fatoumata Diallo, Kaho Onomichi, Jiyeon Son, Zongqi Xia, Philip L. De Jager   +7 more
wiley   +1 more source

Depth inversion illusion and its relationship to positive symptoms in clinical and non-clinical voice hearers. [PDF]

Cogn Neuropsychiatry
Erickson MA, Li C, Bansal S, Waltz J, Corlett P, Gold J.   +5 more
europepmc   +1 more source

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

, 2023
Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton B, Ali M, Haidar A, Billah T, Huynh K, Ahmed U, Adery LL, Corcoran CM, Perkins DO, Schiffman J, Perez J, Mamah D, Ellman LM, Powers AR, Coleman MJ, Anticevic A, Fusar-Poli P, Kane JM, Kahn RS, McGorry PD, Bearden CE, Shenton ME, Nelson B, Calkins ME, Hendricks L, Bouix S, Addington J, McGlashan TH, Yung AR, the Accelerating Medicines Partnership Schizophrenia, AMP SCZ Working Group and Subgroup leaders (not previously listed):, Allott K, Clark SR, Kapur T, Lavoie S, Lewandowski KE, Mathalon DH, Pasternak O, Stone WS, Torous J, National Institute of Mental Health Project Scientists:, Rowland LM, Zhan M, Research Network and DPACC Investigators (not previously listed):, Amminger P, Arango C, Broome MR, Cadenhead KS, Chen EY, Choi J, Kevin Cho KI, Conus P, Cornblatt BA, Glenthøj LB, Horton LE, Kambeitz J, Keshavan MS, Koutsouleris N, Langbein K, Diaz-Caneja CM, Mittal VA, Nordentoft M, Gaspar Ramos PA, Pearlson GD, Shah JL, Smesny S, Strauss GP, Wang J, Study Coordinators and Project Managers (not previously listed):, Marcy PJ, Matneja P, Phassouliotis C, Ray S, Snowball C, Spark J, Tod S, Individual names of AMP SCZ collaborators are listed in the Acknowledgment.   +89 more
europepmc   +1 more source